Drug Trial Radar · NCT04181723
Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)
Last checked: Nov 19, 2026Latest source record: Apr 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
187
Actual
Start
Nov 6, 2019
Primary completion
Oct 28, 2021
Study completion Oct 28, 2021
Sponsor
- Lead sponsor
- ACADIA Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 29, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 5 years, up to 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To investigate the efficacy of treatment with oral trofinetide versus placebo in females with Rett syndrome
Conditions
- Rett Syndrome
Interventions
TrofinetideDrug
Trofinetide solution administered based on the subject's weight at Baseline, twice daily for 12 weeks
PlaceboOther
Trofinetide placebo solution administered based on the subject's weight at Baseline, twice daily for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rett Syndrome Behaviour Questionnaire (RSBQ) Total Score - Change From Baseline to Week 12Time frame: Baseline and Week 12
- Clinical Global Impression-Improvement (CGI-I) Score at Week 12Time frame: 12 Weeks Treatment Duration
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Translational Gemomics Research Institute (TGen)
Phoenix, Arizona
University of California, San Diego
La Jolla, California
UC Davis MIND Institute
Sacramento, California
Children's Hospital Colorado
Aurora, Colorado
Children Medical Services
Tampa, Florida
Emory Genetics Clinical Trial Center
Atlanta, Georgia
Rush University Children's Hospital
Chicago, Illinois
Kennedy Krieger Institute - Clinical Trials Unit
Baltimore, Maryland
Boston Children's Hospital Harvard Medical School
Boston, Massachusetts
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota
Washington University School of Medicine
St Louis, Missouri
Montefiore Medical Center, Children's Hospital at Montefiore
The Bronx, New York
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Cleveland Clinic
Cleveland, Ohio
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Greenwood Genetic Center
Greenwood, South Carolina
Vanderbilt University Medical Center
Nashville, Tennessee
Texas Children's Hospital
Houston, Texas
Seattle Children's
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.